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Abstract
Background:  A broad spectrum of cytotoxicity assays is currently used in the fields of
(eco)toxicology and pharmacology. To choose an appropriate assay, different parameters like test
compounds, detection mechanism, specificity, and sensitivity have to be considered. Furthermore,
tissue or cell line can influence test performance. For zebrafish (Danio rerio), as emerging model
organism, cell lines are now increasingly used, but few studies examined cytotoxicity in these cell
systems. Therefore, we compared four cytotoxicity assays in the zebrafish liver cell line, ZFL, to
test four differently acting model compounds. The tests comprised two colorimetric assays (MTT
assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide, and the LDH assay
detecting lactate dehydrogenase activity) and two fluorometric assays (alamarBlue® using resazurin,
and CFDA-AM based on 5-carboxyfluorescein diacetate acetoxymethyl ester). Model compounds
were the pharmaceutical Tamoxifen, its metabolite 4-Hydroxy-Tamoxifen, the fungicide Flusilazole
and the polycyclic aromatic hydrocarbon Benzo[a]pyrene.
Results: All four assays performed well in the ZFL cells and led to reproducible dose-response
curves for all test compounds. Effective concentrations causing 10% or 50% loss of cell viability
(EC10 and EC50 values) varied by a maximum factor of 7.0 for the EC10 values and a maximum factor
of 1.8 for the EC50 values. The EC values were not statistically different between the four assays,
which is due to the assessed unspecific effects of the compounds. However, most often, the MTT
assay and LDH assay showed the highest and lowest EC values, respectively. Nevertheless, the
LDH assay showed the highest intra- and inter-assay variabilities and the lowest signal-to-noise
ratios. In contrast to MTT, the other three assays have the advantage of being non-destructive, easy
to handle, and less time consuming. Furthermore, AB and CFDA-AM can be combined on the same
set of cells without damaging the cells, allowing later on their use for the investigation of other
endpoints.
Conclusion: We recommend the alamarBlue and CFDA-AM assays for cytotoxicity assessment
in ZFL cells, which can be applied either singly or combined.
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Background
The detection of cell viability is crucial in many biological
fields, e.g. in toxicology, in pharmacology (drug develop-
ment), as well as in ecotoxicology for the assessment of
toxic effects elicited by chemicals, drugs or contaminated
environmental samples, respectively. The need for relia-
ble, easy to handle, and fast cytotoxicity tests led to the
development of several assays which are now routinely
used and available to detect cytotoxic effects in in vitro cel-
lular systems.
One of the mostly used cytotoxicity or cell proliferation
assays is the MTT assay, which is a quantitative colorimet-
ric assay. In this assay, the yellow tetrazolium salt MTT (3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bro-
mide) is reduced by living cells to blue formazan crystals,
which must be solubilized in a solvent, such as iso-propa-
nol [1]. It was assumed that the tetrazolium salt is reduced
in mitochondrial processes at two sites of the respiratory
chain [2], but later on it was shown, that also microsomal
and cytosolic fractions are involved in the formation of
formazan [3,4]. The MTT assay appeared to be a sensitive
test which shows linearity over a broad range of cell den-
sities [1,5].
Another commonly used assay is the lactate dehydroge-
nase (LDH) assay. It is a colorimetric assay based on the
detection of LDH activity which is released from the
cytosol of damaged or lysed cells. Thus the evaluation of
cytotoxicity is based on plasma membrane integrity [6,7].
It is a non-destructive measurement technique since it can
be performed using the culture medium. Also in this
assay, a tetrazolium salt, INT (2-[4-iodophenyl]-3-[4-
nitrophenyl]-5-phenyltetrazolium chloride), is involved
in the colorimetric reaction. Coupled to the oxidation of
lactate to pyruvate, INT is transformed to formazan which
can be detected spectrophotometrically. Another possibil-
ity is to measure directly the formation of NADH by
absorption [8]. Since LDH is a relatively stable enzyme
[7], the culture medium can also be stored before per-
forming the measurement [8].
A further assay, working similarly as MTT, is the alamar-
Blue (AB) assay, which measures cellular metabolic activ-
ity. The AB assay is based on the conversion of the blue
non-fluorescent dye resazurin, which is converted by
mitochondrial and other enzymes to the pink fluorescent
resorufin [4,9]. Resorufin can be detected spectrophoto-
metrically or fluorometrically [10]. Since both, the oxi-
dized substrate resazurin and the reduced product
resorufin, are water soluble, they can freely diffuse along
concentration gradients. In addition, AB shows no cyto-
toxic effects and the tested cells do not need to be
destroyed, thus enabling to perform several tests or kinetic
measurements on the same set of cells [9,11,12].
CFDA-AM (5-carboxyfluorescein diacetate acetoxymethyl
ester) is another fluorogenic dye, which is used for cyto-
toxicity studies, indicating plasma membrane integrity.
The dye CFDA-AM is a non-toxic esterase substrate that
can be converted by nonspecific esterases of living cells
from a membrane permeable, nonpolar, nonfluorescent
substance to a polar, fluorescent dye, carboxyfluorescein
(CF). The conversion to CF by the cells indicates the integ-
rity of the plasma membrane, since only an intact mem-
brane can maintain the cytoplasmic milieu which is
needed to support esterase activity [10]. AB and CFDA-AM
were already shown to be applicable in parallel on the
same set of cells, since both are non-toxic to cells, require
similar incubation times, and can be detected at different
wavelengths without interferences [10-14].
The performance of cytotoxicity assays strongly depends
on tissue or cell line under investigation. Therefore, before
choosing a cytotoxicity assay for a new application, differ-
ent methods should be compared. Along these lines, the
current study had two major aims: firstly, to test the com-
patibility of these assays with the zebrafish (Danio rerio)
liver cell line ZFL [15] and to set up the optimal test con-
ditions. Secondly, to identify which test or test combina-
tion could deliver most useful information for
cytotoxicity studies in ZFL cells since, to our knowledge,
there is not much experience available on cytotoxicity
assays in the ZFL cell line. Few data have been published
on MTT and AB, which were applied each once to assess
cell viability in presence of arsenite and heavy metals,
respectively [16,17]. For evaluating the four above men-
tioned assays, we investigated four model compounds
from three different substance groups: the polycyclic aro-
matic hydrocarbon Benzo[a]pyrene (BaP), the triazole
fungicide Flusilazole (Flus), the pharmaceutical
Tamoxifen (Tam) and its active metabolite 4-Hydroxy-
Tamoxifen (4-OHT).
Results
In the first step, all assays were established in the ZFL cell
line investigating different influencing parameters, such
as cell number per well or medium constitution, before
testing the model compounds to compare the assay per-
formances.
For the MTT assay, a commercially available kit was used.
Therefore, only the parameters cell density and incuba-
tion time were examined. Incubation of the cells with
MTT for 2, 4, or 6 h led to no significant differences in
absorption. Therefore, a four hour incubation time was
applied as suggested in the manufacturer's protocol. In
addition, different cell densities were used to optimize test
conditions. A linear relationship between cell number
and absorption could be established for up to 50,000
cells/well (R2 = 0.95) (Figure 1A). However, since cell den-BMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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Effects of different cell densities Figure 1
Effects of different cell densities. Effects of different cell densities were studied in the four cytotoxicity assays and the lin-
ear range determined by linear regression. For all assays 25,000 cells/well was selected to be used as standard cell number in 
the cytotoxicity tests, which was included in the linear range for all assays. Panel A shows the results for the LDH and MTT 
assays with the Y-axis indicating absorption with respect to the reference wavelengths, i.e. abs590 with reference at 655 nm for 
LDH and abs570 with reference at 680 nm for MTT. Panel B shows linearity for the AB and CFDA-AM assays, with the Y-axis 
indicating the fluorescent units [FU] detected at 530 nm excitation/590 nm emission for AB and 485 nm/535 nm for CFDA, 
respectively.BMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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sities of ≤12,500 cells/well led to relatively low signals,
25,000 cells/well were used in optimized standard tests
conditions.
The effect of different cell densities was also investigated
for the LDH assay for which we used a commercially avail-
able kit. Since the LDH assay detects lysed and not viable
cells, the cells need to be destroyed for these investigations
to optimize test conditions. Therefore, the positive control
Triton X-100 was used, at the concentration of 2% to com-
pletely lyse the cells. A linear relationship between cell
number and absorption was observed (R2 = 0.99) and
25,000 cells/well were used as standard condition (Figure
1A). Furthermore, the effect of FBS on the LDH activity
was investigated, and we observed that lowering the
amount of FBS to 1% in the medium greatly reduced back-
ground values (see Materials and Methods). Conse-
quently, 1% FBS was used in the standard test condition.
The AB and CFDA-AM assay were established directly in
combination, since many examples in the literature
showed that there were no interferences of the two dyes in
other cellular systems, such as e.g. in the rainbow trout gill
cell line RTgill-W1 [10,11] as well as in primary hepato-
cytes from mouse and rainbow trout and in the cell lines
HepG2 and RTL-W1 [18]. The simplified Earle's-G
medium [19], which was used to replace the standard ZFL
culture medium during measurement, was shown to have
no negative effect on cell viability. Furthermore, test per-
formance was examined using different cell densities and
a linear relationship between fluorescence and cell
number was found for cell densities up to 25,000 cells/
well with a correlation coefficient R2 of 0.99 for AB and
0.98 for CFDA-AM, respectively (Figure 1B).
Applying the established assays to test the four model
compounds in ZFL cells, all four assays performed well
and led to reproducible dose-response curves (Fig. 2, 3, 4).
We determined effective concentrations causing a 10% or
50% inhibition of cell viability for each compound except
for BaP. Indeed, for BaP cytotoxic effects were not higher
than 37% even at concentrations either close to or above
the aqueous solubility (data not shown). Therefore, effec-
tive concentrations could not be calculated for none of the
assays for BaP.
For the three other test compounds, effective concentra-
tions were calculated (Table 1). For exposure of ZFL cells
to Tamoxifen, the LDH assay was the most sensitive,
whereas CFDA-AM showed the highest EC10 and MTT the
highest EC50 value. For 4-OHT experiments, LDH
showed the lowest EC10, while CFDA-AM showed the
lowest EC50 value, and the MTT assay was the least sensi-
tive. For Flusilazole, the AB assay led to the highest EC10
and EC50 values. The LDH assay and CFDA-AM assay
were similar to the 4-OHT experiment, in terms of lowest
EC10 and EC50 value, respectively. However, the
observed differences between the EC values from the dif-
ferent assays for each test compound were relatively small
with a maximum factor of 1.8 occurring for EC50 values
and a maximum factor of 7.0 for EC10 values. The devia-
tions between the different assay EC values were not sta-
tistically significant for none of the compounds (One way
ANOVA, Tukey's test, p < 0.05).
For comparison of the four cytotoxicity assays, the param-
eters intra- and inter-assay variability, as well as signal-to-
noise ratio were determined (Table 2). The intra-assay var-
iabilities were measured using triplicate samples within
each experiment and are illustrated in Figure 2, 3, 4 as
error bars representing the standard deviation. The coeffi-
cients of variance (CV) were calculated at high and low
effect levels (Table 2). The AB, CFDA-AM, and MTT assays
showed low variability at higher signals, i.e. at higher
cytotoxicities, and higher variability at low cytotoxicities,
whereas the LDH assay showed overall high intra-assay
variability. The inter-assay variability was derived from
the EC10 and EC50 values calculated for each of the three
individual experiments (Table 1 and 2). Inter-assay varia-
bility was higher for all assays at the EC10 level than at the
EC50 level. The LDH assay showed CV values at both levels
which were approximately the double of the CV values for
the other three assays, thus indicating a much higher
inter-assay variability. Furthermore, the signal-to-noise
ratios were calculated using the signals from wells without
cells as background noise values. For the AB, CFDA-AM,
and the MTT assay, with all of them detecting live cells,
low ratios close to background level were observed at high
compound concentrations causing 80–100% loss of cell
viability, whereas ratios of 28, 7, and 22 were observed for
the AB, CFDA-AM, and MTT assay, respectively, at the low-
est compound concentrations (0–20% cytotoxicity). For
the LDH assay, which detects released enzyme activity
from lysed cells, signals were close to background level at
low compound concentrations. Maximum ratios for LDH
were observed at the higher compound concentrations
with a ratio of 2.2.
Discussion
Four different assays were established in the zebrafish
liver cell line ZFL to detect the cytotoxicity upon exposure
to the four tested compounds, Benzo[a]pyrene (BaP),
Tamoxifen (Tam), its metabolite 4-Hydroxy-Tamoxifen
(4-OHT) and Flusilazole (Flus). BaP is known to act as a
dioxin-like compound, inducing CYP1A1 in juvenile
zebrafish and its embryos, but also inducing CYP19 and
vitellogenin [20-22]. The presence and inducibility of
CYP1A1 in ZFL cells was shown using the dibenzodioxin
TCDD [23,24] and induction of cyp1A1 gene expression in
BaP exposed ZFL cells was confirmed [25]. BaP wasBMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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reported to be metabolized via CYP1A and to form DNA
adducts [26]. Tam is a widely used pharmaceutical agent
for breast cancer treatment, which is biotransformed to its
active metabolite 4-OHT [27]. Tam and 4-OHT have been
shown to stimulate oocyte maturation for zebrafish in vivo
[28]. Furthermore, Tam led to increased perturbations
and mortality in a partial-life cycle test with zebrafish
[29]. Flus is a sterol biosysnthesis inhibiting triazole fun-
gicide, which blocks the enzyme 14-α-demethylase [30]
and interferes also with sterol pathways in mammals
[31,32]. However, so far no studies are reported in
zebrafish, neither in vitro nor in vivo.
All the assays performed well and no significant differ-
ences were found for the EC values from the different
assays for each of the substances. This might be explained
by the fact that none of these compounds specifically
interferes with the processes involved in the mechanism
of the assays.
On the other hand, such results give the possibility to
compare in an unbiased way all the assays. Based on the
detected EC values, they can all be recommended for the
application to ZFL cells. However, assessing the assays
based on all investigated parameters, i.e. EC values, sig-
nal-to-noise ratio, inter- and intra-variability, slight differ-
ences arose among them. Indeed, the LDH assay showed
Cytotoxic effects of Tamoxifen Figure 2
Cytotoxic effects of Tamoxifen. Dose-response curves for cell viability assessment in ZFL cells exposed to Tamoxifen 
using the four different assays. Closed circles represent the mean of the measured triplicate wells with vertical lines indicating 
the standard deviation within one single experiment. The continuous line represents the fitted dose-response curve while 
dashed lines indicate the 95% confidence interval.BMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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often the lowest EC values, as also reported in the litera-
ture by Kemp and Brouwer (2004) [33], which might be
due to the difference that it is the only one of the four
tested assays detecting lysed cells, whereas the others
detect live cells. On the other hand, it was the one with the
lowest signal-to-noise ratios and the highest inter- and
intra-assay variabilities, thus making the detection of low
cytotoxic effects very difficult. Moreover, the LDH assay
uncertainties increase at lower compound concentrations,
which is the opposite for the other three assays. Hence, it
can be summarized for the LDH assay that it has the
advantage of using only a part of the culture medium, thus
enabling the use of the unaffected cells for further analy-
sis, but even if showing the lowest EC values, it entails the
disadvantage of the highest variabilities.
The MTT assay showed much lower variabilities and
higher signal-to-noise ratios than the LDH assay. How-
ever, the highest EC values were observed for the MTT
assay and in contrast to all other three assays, the MTT
assay requires the destruction of the cells for the analysis,
thus making it impossible to use the cells for other inves-
tigations and additionally it is more time consuming. On
the other hand it has the advantage that no washing steps
are needed and reagents are added directly to the medium,
preventing enhanced variability due to procedural steps.
Cytotoxic effects of 4-Hydroxy-Tamoxifen Figure 3
Cytotoxic effects of 4-Hydroxy-Tamoxifen. Dose-response curves for cell viability assessment in ZFL cells exposed to 4-
OH-Tamoxifen using the four different assays. Closed circles represent the mean of the measured triplicate wells with vertical 
lines indicating the standard deviation within one single experiment. The continuous line represents the fitted dose-response 
curve while dashed lines indicate the 95% confidence interval.BMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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The AB and CFDA-AM assays showed, similarly to the
MTT assay, low variabilities and high signal-to-noise
ratios, suggesting that these assays are more precise and
robust than the LDH assay. Furthermore, as for the LDH
assay, they are nondestructive assays, which can be per-
formed within a very short time. Both can be detected
spectrophotometrically or fluorometrically [10]. AB and
CFDA-AM exert no toxic effects on the cells so that even
after cell viability measurement cells might be used to
examine other endpoints. For example, it was shown
before that a combined AB/CFDA-AM assay did not affect
the results of later gene expression analysis of hepatocytes
from rainbow trout (Oncorhynchus mykiss) [12].
Conclusion
Based on the assessed parameters and handling of the four
different assays, we recommend the AB and the CFDA-AM
assay for cytotoxicity assessment. Our data show that
these two assays can be also easily applied in combination
to ZFL cells, thus enabling the simultaneous assessment of
two different endpoints.
Methods
Routine culture of zebrafish liver cells (ZFL)
The zebrafish (Danio rerio) liver cell line ZFL [15] was
obtained from ATCC (Promochem). Cells were cultured
in medium composed of 50% Leibovitz L-15, 35%
Cytotoxic effects of Flusilazole Figure 4
Cytotoxic effects of Flusilazole. Dose-response curves for cell viability assessment in ZFL cells exposed to Flusilazole using 
the four different assays. Closed circles represent the mean of the measured triplicate wells with vertical lines indicating the 
standard deviation within one single experiment. The continuous line represents the fitted dose-response curve while dashed 
lines indicate the 95% confidence interval.BMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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DMEM, and 15% Ham F-12, supplemented with 15 mM
HEPES, 0.15 g/L NaHCO3, 0.01 mg/mL insulin, 50 ng/mL
epidermal growth factor (EGF), and 5% fetal bovine
serum (FBS) as proposed by ATCC. Cells were cultured at
28°C in 75 cm2 cell culture flasks (Stratagene). Cells were
subcultured every 5–7 days. For this purpose, they were
first rinsed with 1 mL of 0.25% trypsin EDTA (Gibco), and
then detached with 1 mL of trypsin EDTA. Trypsination
was stopped by addition of 5 mL of 10% FBS containing
medium. Cells were centrifuged for 5 min at 300 g. Cell
pellets were resuspended in 5% FBS containing medium
and either split to new flasks or plated in 96 well flat-bot-
tom culture plates for cytotoxicity assays.
Exposure of ZFL cells for cytotoxicity assessment
For comparison of the four cytotoxicity assays, cells were
exposed to four differently acting model compounds: the
polycyclic aromatic hydrocarbon Benzo[a]pyrene (BaP;
purity  ≥ 97%, Fluka), the fungicide Flusilazole (Flus;
purity 99.8%, Riedel-de Haën), the pharmaceutical
Tamoxifen (Tam) as Tamoxifen citrate (purity ≥ 99%,
Sigma) and its metabolite trans-4-Hydroxy-Tamoxifen (4-
OHT; purity ≥ 98%, Sigma). Each compound was dis-
solved in dimethyl sulfoxide (DMSO) and diluted in a
way that all stock solutions were 200 times concentrated
compared to the final test concentrations. Concentration
ranges were 30 pM-1.97 μM for BaP, 5 nM-5 μM for Flus,
5 nM-11 μM for Tam, and 0.2–43 μM for 4-OHT, which is
in the range of in vivo studies with waterborne exposure of
zebrafish for BaP, Tam, and 4-OHT [20-22,29]. For
Flusilazole, no studies on fish are available.
For finding the optimal biological test conditions, in the
beginning different cell densities were applied using two-
fold dilution series in the range of 780–100,000 cells/well
and cell viability tests were performed after 24 h. 25,000
cells/well turned out to be in the optimum range for all of
the tests. Thus, cells were plated in 96 well flat-bottom
plates at an initial cell density of 25,000 cells/well in 200
μL of medium and allowed to settle for 24 h. In parallel,
wells containing only medium without cells were pre-
pared and used later on for background correction. After
the pre-incubation period, for each test compound and
each concentration, 1 μL of the DMSO stock solutions was
added so that the final DMSO content was 0.5%. All tests
were performed at least three times and each time in trip-
licate.
Table 1: 10% and 50% effective concentrations (EC) for cytotoxicity in ZFL cells.
Tamoxifen 4-OH-Tamoxifen Flusilazole
EC10 [μM] EC50 [μM] EC10 [μM] EC50 [μM] EC10 [μM] EC50 [μM]
LDH 0.61 ± 0.67 1.88 ± 1.01 0.73 ± 0.55 1.62 ± 0.01 2.28 ± 3.12 17.37 ± 14.53
MTT 1.39 ± 0.77 3.46 ± 0.70 1.49 ± 0.82 1.78 ± 0.40 11.29 ± 5.88 18.37 ± 14.11
AB 1.37 ± 0.33 3.12 ± 0.25 0.79 ± 0.40 1.17 ± 0.24 16.13 ± 11.44 26.40 ± 7.30
CFDA-AM 2.52 ± 2.14 3.35 ± 0.75 1.08 ± 0.62 1.73 ± 0.67 6.49 ± 1.08 16.68 ± 4.76
Effective concentrations (EC) causing 10 or 50% loss of cell viability were determined from a four parameter logistic equation fitted to the 
experimental data for three individual experiments. EC values shown in the table are mean values from three experiments ± standard deviation. No 
EC values could be determined for BaP since dose-response curves were incomplete (highest concentrations which were already above aqueous 
solubility caused 37% loss in cell viability at most). EC values were not significantly different from each other (One way ANOVA, Tukey's test, p < 
0.05).
Table 2: Quality parameters intra- and inter-assay variability and signal-to-noise ratio for the four cytotoxicity assays.
Intra-assay variability (CV [%]) Inter-assay variability (CV [%]) Signal-to-noise ratio
0–20% cytotoxicity 80–100% 
cytotoxicity
10% cytotoxicity 
(EC10)
50% cytotoxicity 
(EC50)
0–20% cytotoxicity 80–100% 
cytotoxicity
LDH 62 15.5 110 54 1.4 2.2
MTT 118 0.6 55 23 21.6 2.1
AB 130 0.8 51 21 5.7 1.0
CFDA-AM 102 0.3 57 29 22.8 1.1
Variability of cytotoxicity assays based on experiments assessing Tam, 4-OHT, and Flus toxicity. Intra-assay variability was calculated based on 
triplicate wells assessed within one assay and median values were calculated based on three independent experiments. Inter-assay variability was 
calculated as the deviation of effective concentrations based on each three independent experiments. For both, intra- and inter-assay variability, the 
coefficient of variance (CV [%]) is shown in the table. The signal-to-noise ratio was calculated for Tam exposure experiments by dividing the 
absorption or fluorescence in the wells containing untreated or treated cells by the signal in background wells without cells. This was performed for 
each Tam concentration and median values are shown for low (0–20%) and high (80–100%) cytotoxicity ranges.BMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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MTT assay
The MTT assay was performed using the cell proliferation
kit I MTT (Roche) according to the manufacturer's proto-
col. In brief, after 24 h of incubation with the test com-
pounds, 100 μL of medium were removed from each well.
Then, 10 μL of the MTT solution were added and plates
incubated for 4 h at 28°C. Since the manufacturer recom-
mends incubation at 37°C and ZFL cells have to be incu-
bated at 28°C, we tested different incubation times with
MTT (2, 4, and 6 h) to establish optimized conditions. No
relevant differences were observed for the different time
points, so that the 4 h incubation was used. After the incu-
bation with MTT, the solubilization solution was added
and plates incubated over night. The next day, absorption
of the produced formazan was measured at 570 nm with
680 nm as reference wavelength using a microplate reader
(Infinite 200, Tecan). For data evaluation, background
and reference wavelength corrected absorption values
were averaged for the triplicates and expressed as "% cyto-
toxicity" referring to the untreated control containing only
the solvent DMSO.
LDH assay
A second set of cells was exposed to the test compounds
for the LDH assay, which was performed using the Cyto-
toxicity Detection Kit LDH (Roche). For this assay, a pos-
itive control, leading to 100% cytotoxicity by lysing the
cells completely, was included in the assay. The positive
control was 2% Triton X-100 solution in the assay
medium, as proposed by the manufacturer. After pre-incu-
bation of the cells, before addition of the test compounds,
the growth medium was exchanged from medium con-
taining 5% FBS to medium containing only 1% FBS. Then,
test compounds in DMSO were dosed and plates incu-
bated as for the other assays for 24 h. For testing the
released LDH activity, 100 μL of culture medium were
transferred to a new 96 well plate. 100 μL of the reaction
solution from the kit, containing the detection dye and
the catalyst were then added and absorption was meas-
ured after 30 min at 490 nm with 655 nm as reference
wavelength in an ELISA reader (Model 680, Biorad). As
for the other assays, background values from wells with-
out cells were subtracted and average values for the tripli-
cates calculated. Cytotoxicity was then calculated
according to the following equation: Cytotoxicity (%) =
(experimental value - DMSO control)/(positive control -
DMSO control) × 100.
The above described final test conditions were the result
of preceding tests to optimize the assay described in the
following: it was reported that FBS can lead to high back-
ground values in the LDH assay [8]. Therefore, its influ-
ence was first assessed comparing the normally used
culture medium with 5% FBS to a reduced FBS concentra-
tion of 1%. This was done in presence of 2% Triton X-100.
The positive control substance Triton X-100 has to be
added, since the LDH assay does not detect the viable but
only damaged or completely lysed cells.
Combined alamarBlue® and CFDA-AM assay
The fluorogenic indicator dyes alamarBlue® (AB) (Bio-
Source, Invitrogen) and CFDA-AM (5-carboxyfluorescein
diacetate acetoxymethyl ester; Molecular Probes, Invitro-
gen) were used in combination on a third set of cells, since
it was shown before that their fluorescent products can be
detected at different non-interfering wavelengths [10]. AB
was obtained as ready-to-use stock solution, which had to
be diluted 200 times to obtain the working solution.
CFDA-AM powder was dissolved in DMSO to a stock solu-
tion of 4 mM, which was diluted 1000 times to reach the
4 μM working solution. Working solutions were prepared
in 1× Earle's-G medium [19], which was investigated in
preceding experiments to support ZFL cell viability during
the assay incubation period. For this purpose, cells were
exposed to the dyes dissolved in culture medium without
FBS or in Earle's-G medium. Since Earle's-G medium
showed the same good correlations between cell number
and fluorescence and lower background values it was cho-
sen for standard test conditions. The AB/CFDA-AM assay
was then performed according to [10]. In brief, after 24 h
of incubation with the test compounds, the medium was
aspirated off completely and 100 μL/well of the alamar-
Blue/CFDA-AM working solution were added. After 30
min of incubation, fluorescence was measured at 530 nm
excitation/590 nm emission for AB and 485 nm/535 nm
for CFDA-AM, respectively, using a fluorescence plate
reader (Infinite 200, Tecan). For data evaluation, average
values of triplicates were calculated after background cor-
rection and all average values for the treatments referred
to the DMSO control, in order to express data as "% cyto-
toxicity".
Data evaluation and statistical analysis
For each single assay, data were evaluated separately for
three independent experiments. Dose-response curves
were fitted using a nonlinear-regression sigmoidal dose-
response curve model provided in the GraphPad Prism
software (GraphPad software, Inc., San Diego, USA). EC10
and EC50 values were derived from these fitted curves for
the single experiments. Final EC-values (Table 1) were cal-
culated as average of three independent experiments with
the standard deviation of the mean indicating the varia-
tion. Data from the different assays were statistically com-
pared using One way ANOVA analysis with Tukey's test as
post-ANOVA analysis (p < 0.05).
Intra-assay variabilities were calculated as coefficient of
variance (CV), based on the triplicate values within each
individual experiment. In a second step, CV values for the
three individual experiments for each tested compoundBMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
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were determined calculating the median CV in a low (0–
20%) and high (80–100%) cytotoxicity range. The inter-
assay variability was assessed based on the EC10 and EC50
values. Median CV values were calculated using the EC
values from each three individual experiments for each
tested compound. Signal-to-noise ratios were calculated
based on Tam exposure experiments for each compound
concentration tested. Average absorption or fluorescence
signals from wells with differently treated cells were
divided by the average signal from wells containing only
the test medium without cells, representing the back-
ground values. Then, median values for the low (0–20%)
and high (80–100%) cytotoxicity range were calculated.
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zol-2-yl]-2,5-diphenyl tetrazolium bromide; Tam:
Tamoxifen.
Authors' contributions
SKB carried out the experimental work. SKB and TL
together conceived of the study and drafted the manu-
script. Both authors read and approved the final manu-
script.
Acknowledgements
We would like to thank Joaquin Pinto Grande for the excellent technical 
support.
References
1. Mosmann T: Rapid colorimetric assay for cellular growth and
survival: application to proliferation and cytotoxicity assays.
J Immunol Methods 1983, 65(1–2):55-63.
2. Slater TF, Sawyer B, Sträuli U: Studies on succinate-tetrazolium
reductase systems III. Points of coupling of four different
tetrazolium salts.  Biochim Biophys Acta 1963, 77:383-393.
3. Berridge MV, Tan AS: Characterization of the cellular reduc-
tion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT): subcellular localization, substrate depend-
ence, and involvement of mitochondrial electron transport
in MTT reduction.  Arch Biochem Biophys 1993, 303(2):474-482.
4. Gonzalez RJ, Tarloff JB: Evaluation of hepatic subcellular frac-
tions for Alamar Blue and MTT reductase activity.  Toxicology
in vitro 2001, 15:257-259.
5. Edmondson JM, Armstrong LS, Martinez AO: A rapid and simple
MTT-based spectrophotometric assay for determining drug
sensititvity in monolayer cultures.  Journal of Tissue Culture Meth-
ods 1988, 11(1):15-17.
6. Korzeniewski C, Callewaert DM: An enzyme-release assay for
natural cytotoxicity.  Journal of Immunological Methods 1983,
64:313-320.
7. Sasaki T, Kawai K, Saijo-Kurita K, Ohno T: Detergent cytotoxicity:
simplified assay of cytolysis by measuring LDH activity.  Toxi-
cology in vitro 1992, 6(5):451-457.
8. Decker T, Lohmann-Matthes ML: A quick and simple method for
the quantitation of lactate dehydrogenase release in the
measurements of cellular cytotoxicity and tumor necrosis
factor (TNF) activity.  J Immunol Methods 1988, 115(1):61-69.
9. O'Brien J, Wilson I, Orton T, Pognan F: Investigation of the
Alamar Blue (resazurin) fluorescent dye for the assessment
of mammalian cell cytotoxicity.  Eur J Biochem 2000,
267:5421-5426.
10. Ganassin RC, Schirmer K, Bols NC: Cell and Tissue Culture.  In
The laboratory fish Edited by: Ostrander GK. San Diego: Academic
Press; 2000:631-651. 
11. Schirmer K, Chan AGJ, Greenberg BM, Dixon DG, Bols NC: Ability
of 16 priority PAHs to be photocytotoxic to a cell line from
the rainbow trout gill.  Toxicology 1998, 127:143-155.
12. Schreer A, Tinson C, Sherry JP, Schirmer K: Application of Alamar
blue/5-carboxyfluorescein diacetate acetoxymethyl ester as
a noninvasive cell viability assay in primary hepatocytes from
rainbow trout.  Analytical Biochemistry 2005, 344:76-85.
13. Bopp SK, Bols NC, Schirmer K: Development of a solvent-free,
solid-phase in vitro bioassay using vertebrate cells.  Environ Tox-
icol Chem 2006, 25(5):1390-1398.
14. Dayeh VR, Lynn DH, Bols NC: Cytotoxicity of metals common
in mining effluent to rainbow trout cell lines and to the cili-
ated protozoan, Tetrahymena thermophila.  Toxicology in vitro
2005, 19:399-410.
15. Gosh C, Zhou YL, Collodi P: Derivation and characterization of
a zebrafish liver cell line.  Cell Biol Toxicol 1994, 10:167-176.
16. Chan KM, Ku LL, Chan PC-Y, Cheuk WK: Metallothionein gene
expression in zebrafish embryo-larvae and ZFL cell-line
exposed to heavy metal ions.  Marine Environmental Research
2006, 62:S83-S87.
17. Seok S-H, Baek M-W, Lee H-Y, Kim D-J, Na Y-R, Noh K-J, Park S-H,
Lee H-K, Lee B-H, Ryu D-Y, Park J-H: Arsenite-induced apoptosis
is prevented by antioxidants in zebrafish liver cell line.  Toxi-
cology in vitro 2007, 21:870-877.
18. Boaru DA, Dragos ¸ N, Schirmer K: Microcystin-LR induced cellu-
lar effects in mammalian and fish priary hepatocyte cultures
and cell lines: a comparative study.  Toxicology 2006,
218:134-148.
19. Schirmer K, Dayeh VR, Bopp S, Russold S, Bols NC: Applying whole
water samples to cell bioassays for detecting dioxin-like
compounds at contaminated sites.  Toxicology 2004,
205:211-221.
20. Cheshenko K, Le Page Y, Hinfray N, Pakdel F, Kah O, Segner H, Eggen
RIL: Expression of zebra fish aromatase cyp19a and cyp19b
genes in response to the ligands of estrogen receptor and
aryl hydrocarbon receptor.  Toxicological Sciences 2007,
96(2):255-267.
21. Hoffmann JL, Oris JT: Altered gene expression: A mechanism
for reproductive toxicity in zebrafish exposed to
benzo[a]pyrene.  Aquatic Toxicology 2006, 78(4):332-340.
22. Kazeto Y, Place AR, Trant JM: Effects of endocrine disrupting
chemicals on the expression of CYP19 genes in zebrafish
(Danio rerio) juveniles.  Aquatic Toxicology 2004, 69(1):25-34.
23. Collodi P, Miranda CL, Zhao X, Buhler DR, Barnes DW: Induction
of zebrafish (Brachydanio rerio) P450 in vivo and in cell cul-
ture.  Xenobiotica 1994, 24(6):487-493.
24. Miranda CL, Collodi P, Zhao X, Barnes DW, Buhler DR: Regulation
of Cytochrome P450 Expression in a Novel Liver Cell Line
from Zebrafish (Brachydanio rerio).  Arch Biochem Biophys 1993,
305(2):320-327.
25. Bopp S, Lettieri T: Gene Expression Profile Assessment in
Zebrafish (Danio rerio).  JRC Scientific and Technical Reports Ispra:
JRC, [EUR 23094 EN] 2007:24.
26. Miranda CL, Chung WG, Wang-Buhler JL, Musafia-Jeknic T, Baird
WM, Buhler DR: Comparative in vitro metabolism of
benzo[a]pyrene by recombinant zebrafish CYP1A and liver
microsomes from β-naphthoflavone-treated rainbow trout.
Aquatic Toxicology 2006, 80(2):101-108.
27. Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM: Metab-
olism of tamoxifen by recombinant human cytochrome
P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and
N-desmethyl metabolites and isomerization of trans-4-
hydroxytamoxifen.  Drug Metab Dispos 2002, 30(8):869-874.
28. Tokumoto T, Tokumoto M, Nagahama Y: Induction and inhibition
of oocyte maturaton by EDCs in zebrafish.  Reprod Biol Endocri-
nol 2005, 3:69.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pharmacology 2008, 8:8 http://www.biomedcentral.com/1471-2210/8/8
Page 11 of 11
(page number not for citation purposes)
29. van der Ven LT, van den Brandhof EJ, Vos JH, Wester PW: Effects of
the estrogen agonist 17β-estradiol and antagonist tamoxifen
in a partial life-cycle assay with zebrafish (Danio rerio).  Envi-
ronmental Toxicology and Chemistry 2007, 26(1):92-99.
30. Zarn JA, Brüschweiler BJ, Schlatter JR: Azole fungicides affect
mammalian steroidogenesis by inhibiting sterol 14α-
demethylase and aromatase.  Environmental Health Perspectives
2003, 111(3):255-261.
31. Menegola E, Broccia ML, Di Renzo F, Massa V, Giavini E: Study on
the common teratogenic pathway elicited by the fungicides
triazole-derivatives.  Toxicology in Vitro 2005, 19(6):737-748.
32. Trosken ER, Scholz K, Lutz RW, Volkel W, Zarn JA, Lutz WK: Com-
parative assessment of the inhibition of recombinant human
CYP19 (aromatase) by azoles used in agriculture and as
drugs for humans.  Endocrine Research 2004, 30(3):387-394.
33. Kemp DC, Brouwer KLR: Viability assessment in sandwich-cul-
tured rat hepatocytes after xenobiotic exposure.  Toxicology in
vitro 2004, 18:869-877.